Hormone Receptor Negative Tumor clinical trials at UCSF

1 research study open to eligible people

A hormone receptor negative tumor is a cancer that does not respond to estrogen or progesterone signals. UCSF is testing new drugs given before surgery to see how the tumors change. UCSF is collecting tumor samples and scans to study which treatments affect these cancers.

Showing trials for

  • I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

    San Francisco, California and other locations

Our lead scientists for Hormone Receptor Negative Tumor research studies include .

Last updated: